Archive for the ‘Enlibrium’ Category


December 15th, 2015 | Posted in 2015, Enlibrium

Enlibrium has raised $15 million in a Series A financing. The cancer drugmaker, which is located in COI Pharmaceuticals (Avalon’s “Community of Innovation” in San Diego), is developing novel drugs based on the anti-cancer activity of metformin. The financing will provide cash to advance Enlibrium’s lead compounds through Phase 1 clinical trial.